13mon MSN
50+ branded semaglutide generics to enter India as diabetes drug patent expires in March 2026
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely ...
Biomea Fusion BMEA shares closed up on Friday as the company is presenting positive data from its Phase II COVALENT-111 study ...
New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 diabetes compared to other diabetes medications.
From online forums to the clinic, people have reported that diabetes and weight-loss drugs such as Ozempic and Wegovy can ...
Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...
Ozempic is intended to help people with diabetes manage blood sugar. A dietitian breaks down exactly what Ozempic is, and if ...
A new Cleveland Clinic study of nearly 8,000 patients found that people who stop popular GLP-1 weight-loss drugs often avoid ...
19don MSN
Novo Nordisk slashing prices for weight-loss and diabetes drugs Ozempic, Wegovy and Rybelsus
Novo Nordisk announced Tuesday it will be slashing the list price of its blockbuster GLP-1 medications, Ozempic, Wegovy and ...
Maryland’s Prescription Drug Affordability Board voted Monday to restrict the price that state and local employees will have to pay for two medicines for type 2 diabetes, Jaridance and Farxiga. The ...
This week, Mad in America examines three studies around mental health diagnosis, psychotropic drug use, obesity, and diabetes ...
The search for long COVID treatments continues, as a randomized clinical trial found that a two-week course of metformin or ursodeoxycholic acid (UDCA) did not meaningfully improve recovery from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results